|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, March 12, 2018 ) North America Proton Therapy Market: By Type of System (Single Room System and Multi-Room System), By Application (Paediatric Cancer, Head & Neck Cancer, Prostate Cancer, Lung Cancer, Gastro-Intestinal Cancer, Brain Cancer and Others), By End-User (Hospitals, Radiotherapy Centres and Others) and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
Market Outline: North America Proton Therapy Market
Proton therapy is also known as proton beam radiation therapy. Proton is a positively charged particle, and in high energy levels protons can destroy the cancer cells. Proton therapy is a non-invasive procedure in which proton radiation used to treat cancer. Proton therapy is a type of external beam radiation therapy, which painlessly delivers radiation through the skin from outside of the body. For the treatment of cancer, proton therapy may be prescribed alone or along with the other treatments such as surgery, chemotherapy, general radiation therapy and or immunotherapy.
A sample of this report is available upon request @https://www.precisionbusinessinsights.com/market-reports/north-america-proton-therapy-market/#ulp-4H8Z4LpNMLEuOnnx
Market dynamics: North America Proton Therapy Market
North America proton therapy market is mainly driven by an increase in the adaptation radiation therapies in the treatment of cancer. Addition to this, growing number of radiotherapy centers in North America coupled with the increase in the prevalence of the cancer cases expected to bolster the market growth of North America proton therapy market over the forecast period. However, high-cost treatment and stringent regulatory procedures are expected to act as restraints for the market growth during the forecast period.
Market Scope: North America Proton Therapy Market
North America proton therapy market is segmented based on type of system, application, and end user
Based on type of system, North America proton therapy market is segmented into
• Single Room System
• Multi-Room System
Based on application, North America proton therapy market is segmented into
• Paediatric Cancer
• Head & Neck Cancer
• Prostate Cancer
• Lung Cancer
• Gastro-Intestinal Cancer
• Brain Cancer
• Others
Based on end user, North America proton therapy market is segmented into
• Hospitals
• Radiotherapy Centres
• Others
To view TOC of this report is available upon request @https://www.precisionbusinessinsights.com/market-reports/north-america-proton-therapy-market/#ulp-c654SbFYO64MsOhu
Country Analysis: North America Proton Therapy Market
Geographically North America proton therapy market is segmented into United States (U.S.) and Canada. U.S. proton therapy market is expected to grow at significant rates owing to the presence of global market players and growing adaptation of the proton therapy for the treatment of cancers such as lung cancer and prostate cancer and growing awareness related to radiation therapy in the treatment of cancer. Canada proton therapy market is expected to have notable growth rate over the forecast period due to the recent product approvals and growing adoption rates of the proton therapy. For instance, In February 2015, Mevion s250 proton system received medical device license from Health Canada, and it is first of its kind to receive the license from Health Canada.
Competition Assessment: North America Proton Therapy Market
Key players profiled in North America proton therapy market include
• Varian Medical Systems (U.S.)
• Optivus Proton Therapy, Inc. (U.S.)
• Mevion Medical Systems (U.S.)
• Advanced Oncotherapy plc (U.K.)
• ProTom International Inc, (U.S.)
• ProNova Solutions LLC (U.S.)
Notable Market Developments: North America Proton Therapy Market
• In September 2017, Mevion Medical Systems announced the submission of 510 (K) premarket notifications to U.S. Food and Drug Administration for its proton therapy system MEVION S250i with pencil beam hyper scan technology.
• In January 2014, Varian Medical Systems has received FDA 510(k) clearance for its updated ProBeam proton therapy system
Need more information about this report @https://www.precisionbusinessinsights.com/market-reports/north-america-proton-therapy-market/#ulp-14mlyhjMGhVjZqa3
Key Features of the Report:
• The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
• The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
• The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
• The report tracks recent innovations, key developments and startup’s details that are actively working in the market
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
• The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Get access to full summary @https://www.precisionbusinessinsights.com/market-reports/north-america-proton-therapy-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @https://www.precisionbusinessinsights.com
Precision Business Insights
Satya Satya
866-598-1553
satya@pbigp.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
